Literature DB >> 25932132

MicroRNA-221 promotes human non-small cell lung cancer cell H460 growth.

Yiming Xu1, Chongjun Zhong2, Shengguang Ding2, Haitao Huang2, Zhenya Shen3.   

Abstract

MicroRNA (miRNA-221) has been reported to be a regulator of cell proliferation. Here we intended to investigate the role of miRNA-221 in regulating the growth of human non-small cell lung cancer cell line H460. H460 cells were transfected with miRNA-221 mimics/inhibitors or their respective negative controls. Real-time quantitative PCRs (qRT-PCRs) were used to confirm the effects of miRNA-221 mimics and inhibitors in H460 cells while Cell Counting Kit 8 (CCK-8) and 5-Ethynyl-2'-deoxyuridine (EdU) assay were used to access the cell viability and proliferation. P27 and P57, as putative targets of miRNA-221, were determined by qRT-PCRs in H460 cells. We found that overexpression of miRNA-221 led to increased proliferative rate and cell viability in H460 cells while down-regulation of miRNA-221 decreased those effects. P27 but not P57 was identified as a potential target gene of miRNA-221 in H460 as P27 was negatively regulated by miRNA-221 in the protein level. In conclusion, this study suggests that miRNA-221 controls human non-small cell lung cancer cell H460 growth potentially by targeting P57. Inhibition of miRNA-221 represents a novel potential treatment for human non-small cell lung cancer.

Entities:  

Keywords:  MicroRNA; growth; human non-small cell lung cancer

Year:  2015        PMID: 25932132      PMCID: PMC4402779     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  26 in total

Review 1.  The diverse functions of microRNAs in animal development and disease.

Authors:  Wigard P Kloosterman; Ronald H A Plasterk
Journal:  Dev Cell       Date:  2006-10       Impact factor: 12.270

2.  MiR-222 overexpression promotes proliferation of human hepatocellular carcinoma HepG2 cells by downregulating p27.

Authors:  Yue-Feng Yang; Fei Wang; Jun-Jie Xiao; Yang Song; Ying-Ying Zhao; Yan Cao; Yi-Hua Bei; Chang-Qing Yang
Journal:  Int J Clin Exp Med       Date:  2014-04-15

Review 3.  Cell-free nucleic acids as biomarkers in cancer patients.

Authors:  Heidi Schwarzenbach; Dave S B Hoon; Klaus Pantel
Journal:  Nat Rev Cancer       Date:  2011-05-12       Impact factor: 60.716

Review 4.  Regulation of microRNA function in somatic stem cell proliferation and differentiation.

Authors:  Archana Shenoy; Robert H Blelloch
Journal:  Nat Rev Mol Cell Biol       Date:  2014-08-13       Impact factor: 94.444

5.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

6.  Serum microRNA-499 and microRNA-208a as biomarkers of acute myocardial infarction.

Authors:  Junjie Xiao; Bo Shen; Jin Li; Dongcao Lv; Yingying Zhao; Fei Wang; Jiahong Xu
Journal:  Int J Clin Exp Med       Date:  2014-01-15

7.  miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation.

Authors:  Michela Garofalo; Gianpiero Di Leva; Giulia Romano; Gerard Nuovo; Sung-Suk Suh; Apollinaire Ngankeu; Cristian Taccioli; Flavia Pichiorri; Hansjuerg Alder; Paola Secchiero; Pierluigi Gasparini; Arianna Gonelli; Stefan Costinean; Mario Acunzo; Gerolama Condorelli; Carlo Maria Croce
Journal:  Cancer Cell       Date:  2009-12-08       Impact factor: 31.743

Review 8.  MicroRNA in lung cancer.

Authors:  P-Y Lin; S-L Yu; P-C Yang
Journal:  Br J Cancer       Date:  2010-09-21       Impact factor: 7.640

9.  Prediction of mammalian microRNA targets.

Authors:  Benjamin P Lewis; I-hung Shih; Matthew W Jones-Rhoades; David P Bartel; Christopher B Burge
Journal:  Cell       Date:  2003-12-26       Impact factor: 41.582

10.  [Expression of MiRNA-221 in non-small cell lung cancer tissues and correlation with prognosis].

Authors:  Junjie Lv; Lei Xu; Youtao Xu; Mantang Qiu; Xin Yang; Jie Wang; Rong Yin; Lin Xu
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2014-03
View more
  8 in total

1.  MicroRNA-222 promotes human non-small cell lung cancer H460 growth by targeting p27.

Authors:  Chongjun Zhong; Shengguang Ding; Yiming Xu; Haitao Huang
Journal:  Int J Clin Exp Med       Date:  2015-04-15

2.  MiR-223 inhibited cell metastasis of human cervical cancer by modulating epithelial-mesenchymal transition.

Authors:  Yaling Tang; Yifeng Wang; Qionghua Chen; Naxuan Qiu; Yan Zhao; Xueye You
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

3.  c-Myc is a novel Leishmania virulence factor by proxy that targets the host miRNA system and is essential for survival in human macrophages.

Authors:  Lucie Colineau; Ulrike Lambertz; Oriol Fornes; Wyeth W Wasserman; Neil E Reiner
Journal:  J Biol Chem       Date:  2018-06-22       Impact factor: 5.157

4.  Overexpression of MicroRNA-221 is associated with poor prognosis in non-small cell lung cancer patients.

Authors:  Yahui Zhang; Yanpeng Zhao; Shengjie Sun; Zhefeng Liu; Yixin Zhang; Shunchang Jiao
Journal:  Tumour Biol       Date:  2016-01-29

5.  MicroRNA-221 promotes cisplatin resistance in osteosarcoma cells by targeting PPP2R2A.

Authors:  Wen-Chao Yu; Hui-Hao Chen; Yan-Yan Qu; Chun-Wei Xu; Chen Yang; Yan Liu
Journal:  Biosci Rep       Date:  2019-07-10       Impact factor: 3.840

6.  Assessment of Circulating miRNA-17 and miRNA-222 Expression Profiles as Non-Invasive Biomarkers in Egyptian Patients with Non-Small-Cell Lung Cancer.

Authors:  Helal F Hetta; Asmaa M Zahran; Reham I El-Mahdy; Emad Eldin Nabil; Hend M Esmaeel; Ola A Elkady; Azza Elkady; Dina A Mohareb; Mohammed Mahmoud Mostafa; James John
Journal:  Asian Pac J Cancer Prev       Date:  2019-06-01

7.  Prognostic and diagnostic potential of miR-146a in oesophageal squamous cell carcinoma.

Authors:  Cong Wang; Shanghui Guan; Fang Liu; Xuan Chen; Lihui Han; Ding Wang; Effat Un Nesa; Xintong Wang; Cihang Bao; Nana Wang; Yufeng Cheng
Journal:  Br J Cancer       Date:  2016-01-21       Impact factor: 7.640

8.  [Serum MiRNA as Predictive and Prognosis Biomarker in Advanced Stage Non-small Cell Lung Cancer in Indonesia].

Authors:  Arif R Hanafi; Achmad M Jayusman; Serafim Alfasunu; Ahmad H Sadewa; Dibyo Pramono; Didik S Heriyanto; Sofia M Haryana
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2020-04-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.